Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 40 | 2024 | 3418 | 4.870 |
Why?
|
Brain Neoplasms | 41 | 2024 | 8981 | 3.230 |
Why?
|
Cerebellar Neoplasms | 5 | 2024 | 587 | 2.000 |
Why?
|
Medulloblastoma | 5 | 2024 | 679 | 1.690 |
Why?
|
Ependymoma | 4 | 2021 | 320 | 1.620 |
Why?
|
Central Nervous System Neoplasms | 3 | 2022 | 916 | 1.130 |
Why?
|
Azepines | 4 | 2019 | 329 | 1.120 |
Why?
|
Brain Stem Neoplasms | 6 | 2024 | 190 | 0.970 |
Why?
|
Triazoles | 4 | 2019 | 902 | 0.880 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 136 | 0.730 |
Why?
|
Astrocytoma | 6 | 2023 | 775 | 0.720 |
Why?
|
Oncogenes | 3 | 2022 | 1220 | 0.660 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2019 | 1594 | 0.650 |
Why?
|
Child | 51 | 2024 | 79818 | 0.640 |
Why?
|
Population Control | 1 | 2017 | 22 | 0.580 |
Why?
|
Mutation | 21 | 2024 | 29915 | 0.580 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 494 | 0.540 |
Why?
|
Interneurons | 2 | 2020 | 591 | 0.530 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.530 |
Why?
|
Cell Cycle | 3 | 2022 | 2930 | 0.500 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2024 | 2053 | 0.490 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2013 | 33 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2019 | 989 | 0.440 |
Why?
|
RNA-Binding Proteins | 3 | 2017 | 1894 | 0.430 |
Why?
|
Neurogenesis | 1 | 2019 | 855 | 0.420 |
Why?
|
Optic Nerve Glioma | 1 | 2012 | 32 | 0.410 |
Why?
|
Molecular Targeted Therapy | 8 | 2024 | 2796 | 0.350 |
Why?
|
Eye Abnormalities | 1 | 2012 | 241 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9273 | 0.320 |
Why?
|
Histones | 4 | 2024 | 2577 | 0.320 |
Why?
|
Proteins | 3 | 2021 | 6026 | 0.310 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2022 | 2912 | 0.310 |
Why?
|
Neural Stem Cells | 3 | 2020 | 882 | 0.310 |
Why?
|
Optic Disk | 1 | 2012 | 421 | 0.300 |
Why?
|
Pathology, Molecular | 2 | 2023 | 328 | 0.300 |
Why?
|
Cell Cycle Proteins | 6 | 2022 | 3442 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5249 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2024 | 3615 | 0.290 |
Why?
|
Humans | 80 | 2024 | 758406 | 0.290 |
Why?
|
Oligodendroglia | 4 | 2020 | 536 | 0.290 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5786 | 0.280 |
Why?
|
Child, Preschool | 17 | 2024 | 42062 | 0.280 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1247 | 0.280 |
Why?
|
Infant | 15 | 2024 | 36055 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2022 | 367 | 0.260 |
Why?
|
Neoplasms | 8 | 2024 | 22032 | 0.260 |
Why?
|
Hedgehog Proteins | 2 | 2024 | 769 | 0.250 |
Why?
|
DNA Copy Number Variations | 3 | 2022 | 2012 | 0.250 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 16886 | 0.250 |
Why?
|
Transcription Factors | 5 | 2020 | 12094 | 0.240 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 716 | 0.230 |
Why?
|
Genome, Human | 4 | 2021 | 4416 | 0.220 |
Why?
|
Fibroblasts | 1 | 2013 | 4087 | 0.220 |
Why?
|
Gene Dosage | 3 | 2017 | 1218 | 0.210 |
Why?
|
Antineoplastic Agents | 4 | 2024 | 13591 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8506 | 0.210 |
Why?
|
Carboplatin | 2 | 2019 | 788 | 0.200 |
Why?
|
RNA | 2 | 2023 | 2716 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3574 | 0.190 |
Why?
|
Consensus | 4 | 2024 | 3099 | 0.190 |
Why?
|
Craniopharyngioma | 1 | 2024 | 277 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2020 | 367 | 0.190 |
Why?
|
Cloning, Organism | 1 | 2020 | 50 | 0.180 |
Why?
|
Genomics | 4 | 2024 | 5790 | 0.180 |
Why?
|
Epigenesis, Genetic | 6 | 2022 | 3754 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 829 | 0.180 |
Why?
|
INDEL Mutation | 2 | 2020 | 266 | 0.180 |
Why?
|
DNA Damage | 2 | 2022 | 2439 | 0.170 |
Why?
|
Cell Survival | 5 | 2024 | 5781 | 0.170 |
Why?
|
Adolescent | 17 | 2024 | 87892 | 0.170 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.160 |
Why?
|
Combined Modality Therapy | 4 | 2023 | 8530 | 0.160 |
Why?
|
Molecular Biology | 1 | 2022 | 580 | 0.160 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 115 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2024 | 64378 | 0.150 |
Why?
|
Mice | 14 | 2024 | 81101 | 0.150 |
Why?
|
Disease-Free Survival | 4 | 2018 | 6821 | 0.150 |
Why?
|
Comparative Genomic Hybridization | 2 | 2017 | 473 | 0.150 |
Why?
|
S Phase | 1 | 2019 | 422 | 0.150 |
Why?
|
Genomic Structural Variation | 1 | 2018 | 63 | 0.150 |
Why?
|
Pyrimidinones | 1 | 2020 | 383 | 0.150 |
Why?
|
Glioblastoma | 2 | 2023 | 3480 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2017 | 79 | 0.140 |
Why?
|
Indazoles | 1 | 2018 | 302 | 0.140 |
Why?
|
Cell Lineage | 3 | 2022 | 2533 | 0.140 |
Why?
|
Epigenomics | 1 | 2022 | 936 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11709 | 0.140 |
Why?
|
Neurocytoma | 1 | 2016 | 29 | 0.140 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
Transcription, Genetic | 4 | 2020 | 7590 | 0.140 |
Why?
|
Glutathione | 1 | 2019 | 579 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2019 | 345 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 2 | 2022 | 4485 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1129 | 0.130 |
Why?
|
Autopsy | 1 | 2019 | 1003 | 0.130 |
Why?
|
Pituitary Neoplasms | 1 | 2024 | 1313 | 0.130 |
Why?
|
Receptor, trkB | 1 | 2016 | 125 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 202 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2019 | 555 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17768 | 0.130 |
Why?
|
Animals | 18 | 2024 | 167768 | 0.120 |
Why?
|
Publications | 1 | 2017 | 194 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1611 | 0.120 |
Why?
|
Pyridones | 1 | 2020 | 784 | 0.120 |
Why?
|
Apoptosis | 4 | 2023 | 9468 | 0.120 |
Why?
|
Genomic Instability | 1 | 2018 | 704 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36284 | 0.120 |
Why?
|
Recurrence | 2 | 2023 | 8426 | 0.110 |
Why?
|
Chromatin | 2 | 2022 | 2938 | 0.110 |
Why?
|
Daunorubicin | 1 | 2013 | 156 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
Male | 23 | 2024 | 358747 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1136 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 772 | 0.110 |
Why?
|
Cell Proliferation | 6 | 2022 | 10416 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2023 | 1245 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39059 | 0.100 |
Why?
|
Astrocytes | 2 | 2020 | 1337 | 0.100 |
Why?
|
Chromosome Mapping | 1 | 2021 | 4624 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1312 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2022 | 4257 | 0.100 |
Why?
|
SEER Program | 1 | 2017 | 1530 | 0.100 |
Why?
|
Female | 23 | 2024 | 390323 | 0.100 |
Why?
|
Radiation Tolerance | 1 | 2013 | 480 | 0.090 |
Why?
|
Second-Look Surgery | 1 | 2011 | 27 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2024 | 80168 | 0.090 |
Why?
|
Young Adult | 8 | 2024 | 58808 | 0.090 |
Why?
|
Survival Analysis | 3 | 2021 | 10112 | 0.090 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1122 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 487 | 0.090 |
Why?
|
Neuroblastoma | 1 | 2018 | 1251 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8553 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 7985 | 0.090 |
Why?
|
Publishing | 1 | 2017 | 833 | 0.090 |
Why?
|
Adult | 13 | 2022 | 219935 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1885 | 0.090 |
Why?
|
NF-kappa B | 1 | 2018 | 2472 | 0.080 |
Why?
|
Etoposide | 1 | 2011 | 630 | 0.080 |
Why?
|
Mice, Inbred NOD | 1 | 2013 | 1825 | 0.080 |
Why?
|
Melphalan | 1 | 2011 | 420 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2895 | 0.080 |
Why?
|
Brain | 5 | 2023 | 26947 | 0.080 |
Why?
|
Gene Amplification | 1 | 2013 | 1085 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1973 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3609 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9404 | 0.080 |
Why?
|
Mice, SCID | 1 | 2013 | 2626 | 0.080 |
Why?
|
Vincristine | 1 | 2011 | 1038 | 0.080 |
Why?
|
Survival Rate | 2 | 2014 | 12721 | 0.080 |
Why?
|
Mice, Nude | 3 | 2019 | 3602 | 0.080 |
Why?
|
Registries | 3 | 2022 | 8175 | 0.070 |
Why?
|
Retinal Detachment | 1 | 2012 | 427 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2017 | 2433 | 0.070 |
Why?
|
Spinal Cord | 1 | 2016 | 1814 | 0.070 |
Why?
|
Immunotherapy | 2 | 2024 | 4641 | 0.070 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 428 | 0.070 |
Why?
|
Medical Oncology | 1 | 2019 | 2312 | 0.070 |
Why?
|
Arousal | 2 | 2002 | 1157 | 0.070 |
Why?
|
Rhabdoid Tumor | 1 | 2008 | 210 | 0.070 |
Why?
|
Clone Cells | 2 | 2020 | 1660 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2114 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2020 | 18940 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3705 | 0.060 |
Why?
|
Cohort Studies | 2 | 2020 | 41256 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2018 | 5199 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18119 | 0.060 |
Why?
|
Remission Induction | 1 | 2011 | 2388 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2218 | 0.060 |
Why?
|
Cisplatin | 1 | 2011 | 1645 | 0.060 |
Why?
|
Signal Transduction | 6 | 2020 | 23342 | 0.060 |
Why?
|
Radiotherapy Dosage | 1 | 2011 | 2896 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2019 | 929 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2008 | 727 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2020 | 4711 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 29557 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6548 | 0.050 |
Why?
|
Sudden Infant Death | 2 | 2002 | 291 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5629 | 0.050 |
Why?
|
Visual Acuity | 1 | 2012 | 2642 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2024 | 326 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1599 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4312 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2024 | 344 | 0.050 |
Why?
|
DNA Repair | 2 | 2024 | 2038 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1737 | 0.050 |
Why?
|
Tryptophan | 1 | 2024 | 479 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 435 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3530 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 311 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 802 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2024 | 627 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9518 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2504 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2001 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2024 | 814 | 0.040 |
Why?
|
Temperament | 1 | 2002 | 295 | 0.040 |
Why?
|
DNA Breaks | 1 | 2020 | 47 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 118 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6768 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 2379 | 0.040 |
Why?
|
Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 347 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 256 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6493 | 0.040 |
Why?
|
Posture | 1 | 2002 | 953 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 331 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4876 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9416 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 802 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 635 | 0.040 |
Why?
|
Age Factors | 3 | 2019 | 18358 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 371 | 0.040 |
Why?
|
Disease Progression | 3 | 2021 | 13468 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5779 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2024 | 2105 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1404 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1752 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2018 | 345 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 998 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1233 | 0.030 |
Why?
|
Virus Integration | 1 | 2018 | 302 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21272 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13245 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2013 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 397 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1739 | 0.030 |
Why?
|
Morpholines | 1 | 2018 | 580 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2020 | 1674 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.030 |
Why?
|
Infant, Newborn | 4 | 2024 | 26183 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2024 | 1585 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3298 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16534 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1507 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1659 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 837 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2018 | 1492 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 698 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1754 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3612 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1871 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14354 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1788 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1477 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2666 | 0.020 |
Why?
|
Brain Stem | 1 | 2017 | 857 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6127 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 503 | 0.020 |
Why?
|
Anaplasia | 1 | 2011 | 16 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9574 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1807 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21017 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3675 | 0.020 |
Why?
|
Microglia | 1 | 2019 | 1349 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 933 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2836 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2925 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1454 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3840 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2858 | 0.020 |
Why?
|
Cell Line | 1 | 2023 | 15591 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1228 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15773 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2011 | 550 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2532 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11070 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2500 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 73809 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2008 | 777 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2697 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3617 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6895 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3258 | 0.020 |
Why?
|
Sleep | 1 | 2002 | 4744 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7378 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3774 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6354 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54137 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1829 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3006 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9267 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3432 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2717 | 0.020 |
Why?
|
Survivors | 1 | 2016 | 2370 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 9460 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3071 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3418 | 0.010 |
Why?
|
Software | 1 | 2018 | 4415 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7016 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12096 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22003 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13285 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10504 | 0.010 |
Why?
|
Prone Position | 1 | 2002 | 196 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12440 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11152 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12604 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7980 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4106 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20055 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3587 | 0.010 |
Why?
|
Polysomnography | 1 | 2002 | 1824 | 0.010 |
Why?
|
United States | 1 | 2022 | 72136 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39872 | 0.010 |
Why?
|
Infant, Premature | 1 | 2002 | 2092 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2002 | 14490 | 0.000 |
Why?
|